Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019

SELL
$97.98 - $114.28 $19,889 - $23,198
-203 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$81.56 - $100.67 $1,875 - $2,315
-23 Reduced 10.18%
203 $20,000
Q4 2018

Jan 16, 2019

SELL
$79.28 - $95.27 $35,676 - $42,871
-450 Reduced 66.57%
226 $19,000
Q3 2018

Oct 30, 2018

SELL
$83.5 - $93.23 $24,298 - $27,129
-291 Reduced 30.09%
676 $61,000
Q2 2018

Jul 17, 2018

SELL
$79.9 - $89.2 $239 - $267
-3 Reduced 0.31%
967 $83,000
Q1 2018

Apr 12, 2018

SELL
$71.51 - $84.69 $32,823 - $38,872
-459 Reduced 32.12%
970 $80,000
Q4 2017

Feb 09, 2018

BUY
$63.24 - $72.8 $90,369 - $104,031
1,429
1,429 $102,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Legacy Financial Advisors, Inc. Portfolio

Follow Legacy Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.